Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFNAR1 (Interferon alpha and beta receptor subunit 1) is a type I membrane protein that forms one of the two essential subunits of the type I interferon receptor complex, partnering with IFNAR2. It binds all type I interferons and upon ligand binding, the receptor chains dimerize, activating JAKs and leading to STAT protein phosphorylation and subsequent transcription of interferon-stimulated genes. It plays a crucial role in antiviral defense and immunomodulation.
Binding to IFNAR1/IFNAR2 heterodimer, activation of JAK/STAT pathway, induction of interferon-stimulated genes (ISGs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type I Interferon Receptor Subunit 1 (None).